-DOCSTART- O

the O
results O
showed O
that O
enriched O
ginger B-Plant
extract O
rhizomes O
exhibited O
the O
highest O
anti O
cancer B-Disease
activity O
on O
mcf O
7 O
cancer B-Disease
cells O
with O
ic50 O
values O
of O
34 O
8 O
and O
25 O
7 O
g O
ml O
for O
fulbaria O
and O
syedpuri O
respectively O

the O
use O
of O
ginger B-Plant
grown O
under O
elevated O
co2 O
concentration O
may O
have O
potential O
in O
the O
treatment O
and O
prevention O
of O
cancer B-Disease

projected O
effects O
of O
tobacco B-Plant
smoking O
on O
worldwide O
tuberculosis B-Disease
control O
mathematical O
modelling O
analysis O

the O
model O
estimated O
that O
aggressive O
tobacco B-Plant
control O
achieving O
a O
1 O
decrease O
in O
smoking O
prevalence O
per O
year O
down O
to O
eradication O
would O
avert O
27 O
million O
smoking O
attributable O
deaths O
from O
tuberculosis B-Disease
by O
2050 O

however O
if O
the O
prevalence O
of O
smoking O
increased O
to O
50 O
of O
adults O
as O
observed O
in O
countries O
with O
high O
tobacco B-Plant
use O
the O
model O
estimated O
that O
34 O
million O
additional O
deaths O
from O
tuberculosis B-Disease
would O
occur O
by O
2050 O

conclusions O
tobacco B-Plant
smoking O
could O
substantially O
increase O
tuberculosis B-Disease
cases O
and O
deaths O
worldwide O
in O
coming O
years O
undermining O
progress O
towards O
tuberculosis B-Disease
mortality O
targeta O
aggressive O
tobacco B-Plant
control O
could O
avert O
millions O
of O
deaths O
from O
tuberculosis B-Disease

elastase O
is O
the O
only O
currently O
identified O
target O
protein O
for O
indole O
3 O
carbinol O
i3c O
a O
naturally O
occurring O
hydrolysis O
product O
of O
glucobrassicin O
in O
cruciferous B-Plant
vegetables I-Plant
such O
as O
broccoli B-Plant
cabbage B-Plant
and O
brussels B-Plant
sprouts I-Plant
that O
induces O
a O
cell O
cycle O
arrest O
and O
apoptosis O
of O
human O
breast B-Disease
cancer I-Disease

toward O
the O
identification O
of O
communities O
with O
increased O
tobacco B-Plant
associated O
cancer B-Disease
burden O
application O
of O
spatial O
modeling O
techniques O

identifying O
areas O
with O
higher O
than O
average O
cancer B-Disease
risk O
and O
smoking O
rates O
then O
targeting O
those O
areas O
for O
intervention O
is O
one O
approach O
to O
more O
rapidly O
lower O
the O
overall O
tobacco B-Plant
disease O
burden O
in O
a O
given O
states O

our O
research O
team O
used O
spatial O
modeling O
techniques O
to O
identify O
areas O
in O
florida O
with O
higher O
than O
expected O
tobacco B-Plant
associated O
cancer B-Disease
incidence O
clusters O

materials O
and O
methods O
geocoded O
tobacco B-Plant
associated O
incident O
cancer B-Disease
data O
from O
1998 O
to O
2002 O
from O
the O
florida O
cancer O
data O
system O
were O
used O

tobacco B-Plant
associated O
cancers B-Disease
included O
lung B-Disease
esophageal B-Disease
and O
h B-Disease
n I-Disease
cancers I-Disease

satscan O
was O
used O
to O
identify O
geographic O
areas O
that O
had O
statistically O
significant O
p O
0 O
10 O
excess O
age O
adjusted O
rates O
of O
tobacco B-Plant
associated O
cancers B-Disease

however O
spatial O
analyses O
may O
be O
most O
useful O
when O
examining O
incident O
clusters O
where O
several O
tobacco B-Plant
associated O
cancer B-Disease
clusters O
overlap O

focusing O
on O
overlapping O
cancer B-Disease
clusters O
may O
help O
investigators O
identify O
priority O
areas O
for O
further O
screening O
detailed O
assessments O
of O
tobacco B-Plant
use O
and O
or O
prevention O
and O
cessation O
interventions O
to O
decrease O
risk O

epidemiological O
evidence O
shows O
that O
regular O
consumption O
of O
brassicaceae B-Plant
is O
associated O
with O
a O
reduced O
risk O
of O
cancer B-Disease
and O
heart B-Disease
disease I-Disease

coriander B-Plant
has O
been O
recommended O
for O
the O
relief O
of O
pain B-Disease
anxiety B-Disease
flatulence B-Disease
and O
loss B-Disease
of I-Disease
appetite I-Disease

in O
traditional O
medicine O
it O
is O
believed O
that O
coriander B-Plant
can O
induce O
some O
degree O
of O
amnesia B-Disease
in O
a O
child O
when O
his O
her O
mother O
uses O
coriander B-Plant
during O
the O
pregancy O

no O
modification O
in O
the O
pain B-Disease
threshold O
was O
elicited O
by O
electric O
stimuli O
both O
in O
coriander B-Plant
and O
control O
groups O

perceived O
health O
risks O
attitude O
and O
readiness O
to O
quit O
tobacco B-Plant
among O
euthymic B-Disease
bipolar I-Disease
disorder I-Disease
patients O
in O
regular O
contact O
with O
mental O
health O
services O
an O
exploratory O
study O
from O
india O

background O
patients O
with O
bipolar O
disorder O
bd B-Disease
are O
at O
higher O
risk O
of O
tobacco B-Plant
related O
harm O
compared O
with O
general O
population O

aim O
the O
study O
aims O
to O
explore O
the O
perceived O
health O
risks O
attitude O
and O
readiness O
to O
quit O
tobacco B-Plant
among O
euthymic O
bd B-Disease
patients O

the O
non O
readiness O
to O
change O
tobacco B-Plant
use O
was O
predicted O
by O
difficulty O
in O
quitting O
due O
to O
mood B-Disease
disorder I-Disease
odds O
ratio O
or O
0 O
229 O
and O
a O
higher O
perceived O
ability O
to O
quit O
or O
328 O

conclusion O
the O
knowledge O
and O
risk O
perception O
for O
tobacco B-Plant
remains O
inadequate O
even O
among O
the O
stable O
bd B-Disease
type I-Disease
i I-Disease
patients O
in O
regular O
contact O
with O
mental O
health O
services O

the O
aim O
of O
this O
review O
is O
to O
summarize O
present O
knowledge O
of O
genetic O
variation O
in O
cytochrome O
p450 O
1b1 O
cyp1b1 O
and O
2c9 O
cyp2c9 O
genes O
and O
risk O
of O
tobacco B-Plant
related O
cancer B-Disease
female O
cancer B-Disease
chronic B-Disease
obstructive I-Disease
pulmonary I-Disease
disease I-Disease
and O
ischemic B-Disease
vascular I-Disease
disease I-Disease

recently O
large O
studies O
on O
the O
association O
between O
genetic O
variation O
in O
cyp1b1 O
and O
cyp2c9 O
and O
risk O
of O
disease O
with O
considerable O
statistical O
power O
rebutted O
the O
hypotheses O
that O
these O
genetic O
variants O
affect O
risk O
of O
tobacco B-Plant
related O
cancer B-Disease
female O
cancer B-Disease
chronic B-Disease
obstructive I-Disease
pulmonary I-Disease
disease I-Disease
and O
ischemic B-Disease
vascular I-Disease
disease I-Disease

fenugreek B-Plant
a O
naturally O
occurring O
edible O
spice O
kills O
mcf O
7 O
human O
breast B-Disease
cancer I-Disease
cells O
via O
an O
apoptotic O
pathway O

trigonella B-Plant
foenum I-Plant
graecum I-Plant
fenugreek B-Plant
is O
traditionally O
applied O
to O
treat O
disorders O
such O
as O
diabetes B-Disease
high B-Disease
cholesterol I-Disease
wounds B-Disease
inflammation B-Disease
and O
gastrointestinal B-Disease
ailments I-Disease

oxyresveratrol O
is O
a O
potent O
antioxidant O
and O
free O
radical O
scavenger O
found O
in O
mulberry B-Plant
wood I-Plant
morus B-Plant
alba I-Plant
l I-Plant
with O
demonstrated O
protective O
effects O
against O
cerebral B-Disease
ischemia I-Disease

background O
olive B-Plant
oil O
consumption O
is O
associated O
with O
a O
decreased O
risk O
of O
several O
chronic B-Disease
diseases I-Disease
in O
particular O
cardiovascular B-Disease
disease I-Disease
cvd B-Disease

objective O
we O
evaluated O
the O
association O
between O
olive B-Plant
oil O
and O
overall O
and O
cause O
specific O
mortality O
in O
the O
spanish O
population O
in O
the O
european O
prospective O
investigation O
into O
cancer B-Disease
and O
nutrition O
epic O
spain O

the O
association O
between O
olive B-Plant
oil O
analyzed O
as O
a O
categorical O
and O
continuous O
variable O
and O
overall O
and O
cause O
specific O
mortality O
cvd B-Disease
cancer B-Disease
and O
other O
causes O
was O
analyzed O
by O
using O
cox O
proportional O
hazards O
regression O
models O
adjusted O
for O
potential O
confounders O

in O
comparison O
with O
nonconsumers O
the O
highest O
quartile O
of O
olive B-Plant
oil O
consumption O
was O
associated O
with O
a O
26 O
95 O
ci O
13 O
36 O
reduction O
in O
risk O
of O
overall O
mortality O
and O
a O
44 O
95 O
ci O
21 O
60 O
reduction O

in O
cvd B-Disease
for O
each O
increase O
in O
olive B-Plant
oil O
of O
10gr O
2000 O
kcal O
d O
there O
was O
a O
7 O
95 O
ci O
3 O
10 O
decreased O
risk O
of O
overall O
mortality O
and O
a O
13 O
95 O
ci O
6 O
20 O
decreased O
risk O
of O
cvd B-Disease
mortality O
no O
significant O
association O
was O
observed O
between O
olive B-Plant
oil O
and O
cancer B-Disease
mortality O

conclusions O
olive B-Plant
oil O
was O
associated O
with O
a O
decreased O
risk O
of O
overall O
mortality O
and O
an O
important O
reduction O
in O
cvd B-Disease
mortality O
in O
this O
large O
mediterranean O
cohort O

areca B-Plant
nut O
chewing O
and O
systemic B-Disease
inflammation I-Disease
evidence O
of O
a O
common O
pathway O
for O
systemic B-Disease
diseases I-Disease

diabetes B-Disease
hypertension B-Disease
cardiovascular B-Disease
diseases I-Disease
oropharyngeal B-Disease
and O
oesophageal B-Disease
cancers I-Disease
have O
been O
associated O
with O
areca B-Plant
nut O
chewing O
and O
the O
mechanism O
by O
which O
areca B-Plant
nut O
chewing O
increases O
the O
risk O
of O
systemic B-Disease
diseases I-Disease
remains O
elusive O

we O
hypothesize O
that O
systemic B-Disease
inflammation I-Disease
may O
be O
elevated O
among O
areca B-Plant
nut O
users O
which O
is O
linked O
with O
many O
systemic B-Disease
disease I-Disease

therefore O
this O
present O
study O
was O
conducted O
to O
examine O
the O
systemic B-Disease
inflammation I-Disease
among O
areca B-Plant
nut O
chewers O
and O
healthy O
control O

increase O
in O
amount O
of O
areca B-Plant
nut O
consumption O
had O
a O
significant O
dose O
response O
relationship O
with O
systemic B-Disease
inflammation I-Disease
p O
for O
trend O

areca B-Plant
nut O
chewing O
has O
a O
significant O
association O
with O
systemic B-Disease
inflammation I-Disease

further O
work O
is O
required O
to O
confirm O
that O
systemic B-Disease
inflammation I-Disease
is O
the O
main O
pathway O
by O
which O
areca B-Plant
nut O
use O
increases O
the O
risk O
of O
systemic B-Disease
diseases I-Disease

rhodiola B-Plant
crenulata I-Plant
root O
ameliorates O
derangements O
of O
glucose O
and O
lipid O
metabolism O
in O
a O
rat O
model O
of O
the O
metabolic B-Disease
syndrome I-Disease
and O
type B-Disease
2 I-Disease
diabetes I-Disease

ethnopharmacological O
relevance O
rhodiola B-Plant
species O
are O
traditionally O
used O
as O
tonics O
and O
stimulants O
to O
treat O
asthenia B-Disease
suggesting O
their O
possible O
regulatory O
effect O
on O
energy O
metabolism O

materials O
and O
methods O
zucker O
diabetic B-Disease
fatty O
zdf O
rats O
were O
treated O
with O
rhodiola B-Plant
crenulata I-Plant
root O
rcr B-Plant
powder O
100 O
and O
500 O
mg O
kg O
by O
gavage O
once O
daily O
for O
4 O
weeks O

in O
addition O
the O
effects O
of O
rcr B-Plant
on O
sucrose O
induced O
acute O
hyperglycemia B-Disease
in O
mice O
and O
olive B-Plant
oil O
induced O
hypertriglyceridemia B-Disease
in O
rats O
were O
also O
examined O

however O
rcr B-Plant
minimally O
affected O
sucrose O
induced O
acute O
hyperglycemia B-Disease
in O
mice O
and O
olive B-Plant
oil O
induced O
acute O
hypertriglyceridemia B-Disease
in O
rats O

conclusions O
the O
present O
results O
demonstrate O
that O
rcr B-Plant
treatment O
improves O
metabolic O
derangements O
in O
animal O
model O
of O
the O
metabolic B-Disease
syndrome I-Disease
and O
type B-Disease
2 I-Disease
diabetes I-Disease

persistent O
cigarette O
smoking O
and O
other O
tobacco B-Plant
use O
after O
a O
tobacco B-Plant
related O
cancer B-Disease
diagnosis O

these O
risks O
may O
be O
even O
higher O
among O
tobacco B-Plant
related O
cancer B-Disease
survivors O
trcs O

we O
describe O
tobacco B-Plant
use O
behaviors O
among O
trcs O
other O
cancer B-Disease
survivors O
and O
people O
without O
a O
history O
of O
cancer B-Disease

methods O
we O
used O
2009 O
behavioral O
risk O
factor O
surveillance O
system O
data O
to O
describe O
demographic O
characteristics O
smoking O
history O
current O
smoking O
prevalence O
and O
smokeless O
tobacco B-Plant
use O
among O
trcs O
other O
cancer B-Disease
survivors O
and O
people O
without O
a O
history O
of O
cancer B-Disease
cigarette O
smoking O
and O
smokeless O
tobacco B-Plant
use O
were O
calculated O
after O
adjusting O
for O
age O
sex O
race O
and O
insurance O
status O

tobacco B-Plant
related O
cancers B-Disease
were O
defined O
as O
lung O
bronchial O
pharyngeal O
laryngeal O
esophageal O
stomach O
pancreatic O
kidney O
renal O
urinary O
bladder O
cervical O
and O
acute B-Disease
myeloid I-Disease
leukemia I-Disease

smokeless O
tobacco B-Plant
use O
was O
higher O
among O
respondents O
without O
a O
history O
of O
cancer B-Disease
4 O
compared O
with O
trcs O
3 O
and O
other O
cancer B-Disease
survivors O
3 O

targeted O
smoking O
prevention O
and O
cessation O
interventions O
are O
needed O
for O
cancer B-Disease
survivors O
especially O
those O
diagnosed O
with O
a O
tobacco B-Plant
related O
cancer B-Disease

we O
provide O
the O
first O
population O
based O
report O
on O
demographic O
characteristics O
and O
tobacco B-Plant
use O
behaviors O
among O
sel O
reported O
tobacco B-Plant
related O
cancer B-Disease
survivors O

epidemiological O
studies O
suggest O
that O
cocoa B-Plant
rich O
products O
reduce O
the O
risk O
of O
cardiovascular B-Disease
disease I-Disease

epidemiological O
studies O
suggest O
that O
cocoa B-Plant
rich O
products O
reduce O
the O
risk O
of O
cardiovascular B-Disease
disease I-Disease

adverse O
effects O
including O
gastrointestinal B-Disease
complaints I-Disease
and O
distaste O
of O
the O
trial O
product O
were O
reported O
by O
5 O
of O
patients O
in O
the O
active O
cocoa B-Plant
intervention O
group O
and O
1 O
of O
patients O
in O
the O
control O
groups O

furthermore O
long O
term O
trials O
investigating O
the O
effect O
of O
cocoa B-Plant
on O
clinical O
outcomes O
are O
also O
needed O
to O
assess O
whether O
cocoa B-Plant
has O
an O
effect O
on O
cardiovascular B-Disease
events I-Disease
and O
to O
assess O
potential O
adverse O
effects O
associated O
with O
chronic O
ingestion O
of O
cocoa B-Plant
products O

aloe B-Plant
emodin O
an O
anthraquinone O
in O
vitro O
inhibits O
proliferation O
and O
induces O
apoptosis O
in O
human O
colon B-Disease
carcinoma I-Disease
cells O

the O
present O
study O
aimed O
to O
investigate O
the O
anticancer O
effect O
of O
aloe B-Plant
emodin O
an O
anthraquinone O
compound O
present O
in O
the O
leaves O
of O
aloe B-Disease
vera I-Disease
on O
two O
human O
colon B-Disease
carcinoma I-Disease
cell O
lines O
dld O
and O
widr O

colon B-Disease
carcinoma I-Disease
cells O
were O
treated O
with O
various O
concentrations O
of O
aloe B-Plant
emodin O
for O
different O
durations O

in O
addition O
exposure O
of O
colon B-Disease
carcinoma I-Disease
cells O
to O
aloe B-Plant
emodin O
suppressed O
the O
casein O
kinase O
ii O
activity O
in O
a O
time O
dependent O
manner O
and O
was O
accompanied O
by O
a O
reduced O
phosphorylation O
of O
bid O
a O
downstream O
substrate O
of O
casein O
kinase O
ii O
and O
a O
pro O
apoptotic O
molecule O

these O
findings O
showed O
that O
the O
inhibition O
of O
casein O
kinase O
ii O
activity O
the O
release O
of O
apoptosis O
inducing O
factor O
and O
cytochrome O
c O
and O
the O
caspase O
3 O
activation O
are O
involved O
in O
aloe B-Plant
emodin O
mediated O
apoptosis O
in O
colon B-Disease
carcinoma I-Disease
cells O

in O
this O
study O
we O
use O
a O
genomic O
approach O
to O
study O
the O
signaling O
processes O
associated O
with O
tobacco B-Plant
smoke O
exposure O
and O
lung B-Disease
cancer I-Disease

furthermore O
our O
findings O
suggest O
that O
the O
airway O
gene O
expression O
signatures O
derived O
in O
this O
study O
can O
provide O
novel O
insights O
into O
signaling O
pathways O
altered O
in O
the O
field O
of O
injury O
induced O
by O
tobacco B-Plant
smoke O
and O
thus O
may O
impact O
strategies O
for O
prevention O
of O
tobacco B-Plant
related O
lung B-Disease
cancer I-Disease

effects O
of O
korean O
red O
ginseng B-Plant
extracts O
on O
neural B-Disease
tube I-Disease
defects I-Disease
and O
impairment B-Disease
of I-Disease
social I-Disease
interaction I-Disease
induced O
by O
prenatal O
exposure O
to O
valproic O
acid O

using O
the O
prenatal O
valproic O
acid O
vpa O
injection O
model O
of O
autism B-Disease
spectrum I-Disease
disorder I-Disease
asd B-Disease
in O
rats O
which O
produces O
social O
impairrment O
and O
altered O
seizure B-Disease
susceptibility O
as O
in O
human O
asd B-Disease
patients O
as O
well O
as O
mild O
neural B-Disease
tube I-Disease
defects I-Disease
like O
crooked B-Disease
tail I-Disease
phenotype I-Disease
we O
examined O
whether O
chronic O
administration O
of O
red O
ginseng B-Plant
extract O
may O
rescue O
the O
social O
impairment O
and O
crooked B-Disease
tail I-Disease
phenotype I-Disease
in O
prenatally O
vpa O
exposed O
rat O
offspring O

vpa O
induced O
impairment O
in O
social O
interactions O
tested O
using O
sociability O
and O
social O
preference O
paradigms O
as O
well O
as O
crooked B-Disease
tail I-Disease
phenotypes I-Disease
were O
significantly O
improved O
by O
administration O
of O
korean O
red O
ginseng B-Plant
krg B-Plant
in O
a O
dose O
dependent O
manner O
